Log In
Print
BCIQ
Print
Print this Print this
 

T1h, itolizumab (Alzumab, Anti-CD6)

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionHumanized IgG1 mAb that inhibits CD6
Molecular Target CD6
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today